查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1835242

心臟移植市場按手術方式、適應症、移植物保存、患者年齡層和最終用戶分類——2025-2032 年全球預測

Heart Transplant Market by Procedure, Indication, Graft Preservation, Patient Age Group, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年心臟移植市場規模將成長至 284.5 億美元，複合年成長率為 10.17%。

主要市場統計數據
基準年2024年 131億美元
預計2025年 144.1億美元
預測年份：2032年 284.5億美元
複合年成長率（%） 10.17%

專注於重塑心臟移植計畫和相關人員決策的當代臨床、供應鏈和策略重點

本執行摘要為現代心臟移植領域提供了重點方向，綜合了臨床進展、供應鏈動態、監管格局以及影響心臟移植項目和行業戰略的營運重點。概述重點介紹了重新定義手術全期護理、器官保存、供體-受體匹配和跨境物流的關鍵曲折點，同時強調了對醫院管理者、移植中心、醫療設備開發商和醫療系統採購方的影響。

本摘要透過對臨床方案和產業趨勢的綜合分析，重點介紹了生態系統面臨的最重要趨勢和挑戰。摘要將臨床品質要求與採購現實和技術機會結合。透過強調即時營運回應和中期策略轉變，本文件為尋求最佳化結果、控制成本和加速採用高價值創新的相關人員提供了切實可行的藍圖。其目的是使臨床醫生、管理人員和供應鏈領導者能夠就優先事項和投資決策進行知情對話，這些優先事項和決策將對未來幾年的專案韌性和患者結果產生重大影響。

器官灌注、手術改進和重新設計的護理模式的技術創新如何催化整個心臟移植輸送系統的結構變化

心臟移植領域正在經歷變革性變革，這得益於技術創新、臨床通訊協定的演變以及器官保存和分配方法的轉變。器官灌注技術的進步延長了器官的存活期，拓寬了捐贈者標準，從而改變了手術時機、受體選擇模式和物流模式。同時，手術技術和手術全期管理的改進正在改善移植物的功能和早期存活率，為各中心重新思考患者治療路徑和容量規劃創造了機會。

其他變革力量包括數據驅動的供體-受體匹配的整合、免疫抑制策略的改進，以及對平衡生存和長期生活品質的多學科移植後護理模式的日益重視。這些整合的發展迫使醫院和移植中心重新評估其基礎設施投資、人員能力以及與設備和保存技術供應商的夥伴關係。隨著這種轉變的展開，專案負責人擴大被要求採用靈活的籌資策略，並在臨床、營運和供應鏈領域開展協作，以在管理複雜性和成本的同時實現臨床效益。

評估 2025 年美國關稅調整如何改變心臟移植護理的採購經濟、供應鏈彈性和技術採用決策

美國2025年實施的政策變化，尤其是關稅調整，為心臟移植供應鏈帶來了層層複雜性，影響了設備、倉儲系統和跨境物流。某些醫療設備和零件的關稅可能會增加移植專用設備的到岸成本，從而影響醫院和移植中心的採購預算。採購成本的上升使專案主管難以權衡，究竟是保留現有供應商，還是投資新興技術？這些新興技術可能帶來臨床效益，但初始購置成本也較高。

關稅主導的成本壓力也影響儲存媒體、一次性組件和灌注平台的全球分銷模式。隨著供應商尋求替代籌資策略、本地庫存和合約保護以降低供應中斷的風險，物流調整措施正在興起。此外，關稅也會透過限制某些耗材的供應或限制需要國際製造組件的新設備的快速部署，間接影響臨床實踐。為了應對這種環境，相關人員正在透過更積極地與供應商就定價進行溝通、投資關鍵耗材的冗餘資源以及重新評估總擁有成本（而不僅僅是領先價格）來維持專案的韌性和臨床的連續性。

以細分市場為重點的臨床和營運現實，涵蓋程序、適應症、保存期限、年齡層和最終用戶，推動採購和專案實施選擇

節段層面的動態變化揭示了不同的臨床和手術要點，這些要點必須納入專案規劃和供應商選擇。異位植入和原位植入之間的手術差異仍然是外科決策的基礎，原位手術又細分為雙心房手術和雙輸卵管手術，這會影響手術全期管理、併發症概況和資源利用率。這些手術分類的差異指南人員配置模式、訓練需求和設備適用性評估。

基於適應症的細分突出了不同的患者群體，包括患有先天性心臟疾病、擴大性心肌病、終末期心臟衰竭和缺血性心肌病變的患者，每種疾病對移植前最佳化要求和移植後護理途徑都有獨特的影響。這些臨床指徵也決定了移植的優先順序和預期的併發症負擔，為住院時間預測和長期追蹤策略提供資訊。機器灌注和靜態低溫儲存之間的移植物保存選擇，以及機器灌注中的低溫和常溫方法之間的移植物保存選擇，會影響運輸物流、灌注人員部署和灌注平台投資的決策。患者年齡層（成人、老年和兒童）的差異對移植物選擇標準、免疫抑制方案和復健計畫有重要影響。最後，醫院和移植中心等最終用戶的規模、病例組合以及與更廣泛的醫療保健系統的整合各不相同，導致採購結構、優先承包方式以及採用新型保存和監測技術的準備程度存在差異。了解這些部分如何相互作用對於協調臨床通訊協定與籌資策略以及製定能夠在不同項目類型中提供一致結果的實施計劃至關重要。

美洲、歐洲、中東和非洲以及亞太地區在臨床應用、監管複雜性和供應鏈策略方面的區域差異將影響實施路徑

區域動態正在塑造臨床實踐模式、法規環境和供應鏈架構，為不同地區的相關人員制定不同的策略重點。在美洲，成熟的移植網路和整合的數據系統正在支援先進的供體-受體匹配和器官保存技術的快速應用。

在歐洲、中東和非洲，由於法律規範和基礎設施成熟度不同，市場呈現兩種發展速度：領先的移植中心採用尖端技術，而許多機構則專注於建立基礎能力和穩定供應鏈。這種區域動態影響著夥伴關係模式和分銷策略。在亞太地區，不斷擴展的臨床能力、不斷發展的監管途徑以及對醫療技術基礎設施的積極投資正在加速新型存儲和監控解決方案的採用，但廣闊地區的物流複雜性和報銷差異可能會影響打入市場策略和本地化工作。跨地區、跨境合作、協調的臨床通訊協定以及與本地經銷商的策略聯盟仍然是成功部署技術並擴展專案的關鍵因素。

競爭態勢的特點是技術創新者、現有設備製造商和服務聯盟優先考慮臨床檢驗、整合和靈活的商業模式

支持心臟移植治療的企業環境特點是，專業技術創新者、成熟的醫療設備製造商以及支援物流和保存的服務供應商構成了混合體。專注於機器灌注和器官保存系統的創新者正在透過平台開發、數據化監控以及與運輸物流的整合，推動傳統冷凍保存模式的轉變。同時，領先的器材製造商正在利用其分銷規模、監管經驗和臨床關係，加速市場滲透，並促進新技術的培訓計畫。

技術開發商、移植物流和物流供應商之間的策略夥伴關係正變得越來越普遍，將臨床檢驗途徑與營運解決方案相結合，以管理器官運輸和設備運作。強調可靠臨床證據、以使用者為中心的設計和生命週期服務支援的公司更有可能被專案負責人接受。隨著客戶尋求將臨床效益與可預測的預算結果相結合，提供靈活商業模式（例如結果驅動合約、託管服務安排和捆綁採購選項）的公司正獲得越來越多的關注。競爭差異化越來越依賴展示臨床價值、無縫整合到臨床工作流程以及對實施後培訓和數據分析的支援。

為醫院管理人員、移植中心領導和供應商提供可行的策略槓桿，以協調採購、臨床實踐和夥伴關係，從而維持專案的彈性和成果。

產業領導者和專案主管應採取果斷措施，將臨床目標與採購和營運策略結合。優先投資於經驗證可提高器官存活率和操作靈活性的儲存平台，並結合完善的培訓計劃和跨學科通訊協定，以確保持續使用並實現效益。同時，採用評估總體擁有成本、供應冗餘和服務等級協定的採購框架，以保護專案免受供應中斷和關稅造成的成本波動的影響。

與物流和技術供應商建立策略夥伴關係，共同設計運輸和儲存工作流程，以減少缺血時間並提高可預測性。投資於數據收集和分析，以衡量臨床結果，識別流程瓶頸，並支持循證合約。最後，與政策制定者和付款人合作，溝通先進儲存技術的臨床和經濟價值，並探索報銷模式和創新的合約方式，將早期採用的獎勵與患者的長期利益相結合。此類合作行動將使您的專案能夠在保持財務紀律和營運彈性的同時獲得臨床效益。

結合臨床文獻、相關人員訪談、通訊協定分析和操作檢驗的嚴格證據綜合提供了可操作的項目級見解

本執行摘要所依據的研究整合了同行評審的臨床文獻、監管指南、手術技術分析以及來自移植臨床醫生、供應鏈負責人和技術開發人員的主要定性意見。資料收集包括與多學科相關人員的結構化訪談、臨床方案和設備說明書的審查，以及與採購和關稅影響相關的政策文件的審查。分析方法將主題定性綜合與不同程序和儲存方式的操作要求的比較評估相結合。

為了確保研究結果與實務工作者和決策者的相關性，調查方法優先考慮了臨床證據、醫療服務提供者能力和實際操作經驗的三方檢定。研究結果透過與移植外科醫生、灌注師和專案經理的反覆諮詢檢驗，以確保與第一線實踐保持一致。本研究明確關注系統層面的影響和技術實施考量，而非詳細的財務估算，從而能夠針對不同的機構背景和準備程度提供切實可行的建議。

整合臨床、營運和策略要點，確定哪些移植項目可以從技術創新中受益，同時保持彈性和病患結果。

總而言之，心臟移植領域正處於曲折點，臨床創新、保存模式的轉變以及供應鏈動態的演變正在匯聚，重新定義專案策略。灌注技術的進步以及外科和手術全期護理的改進，為擴大捐贈者庫和改善療效創造了機會，而政策變化和採購挑戰則要求更複雜的供應鏈和承包方式。成功的專案將整合臨床和手術計劃，採用循證技術並提供適當的培訓和支持，並建立採購結構以管理成本波動和供應風險。

展望未來，最具韌性的移植計畫將把卓越的臨床服務與策略採購、數據主導的績效管理以及貫穿臨床和商業生態系統的夥伴關係相結合。透過將投資與檢驗的臨床效益和營運準備相結合，相關人員可以改善患者治療效果，增強計畫的永續性，並加速採用能夠顯著推進移植治療的創新技術。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 擴大使用機器學習演算法來預測捐贈者的心臟適用性和移植後的生存結果
  • 引入體外心臟灌注系統以延長供體心臟保存時間並改善移植功能
  • 利用基因編輯豬心臟進行異種移植的監管核准和臨床整合，以解決捐贈者短缺問題
  • 針對 B 細胞耗竭的免疫調節療法的進展，可降低心臟移植接受者的慢性排斥率
  • 整合穿戴式式遠端監控設備，用於早期檢測移植排斥和個人化患者管理
  • 3D生物列印研究對自體心臟組織支架開發以緩解器官短缺的影響
  • 供體特異性細胞療法的出現，增強了移植後的耐受性，並最大限度地減少了終身免疫抑制治療
  • 擴大循環死亡後的器官捐贈通訊協定，以增加捐贈者的可用性並降低等候名單上的死亡率
  • 實施人工智慧驅動的決策支援工具，以最佳化器官分配並改善移植中心的工作流程

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 心臟移植市場（依手術類型）

  • 異位移植
  • 原位移植
    • 雙耳法
    • 雙腔靜脈入路

第9章心臟移植市場（按適應症）

  • 先天性心臟疾病
  • 擴大性心肌病
  • 末期心臟衰竭
  • 缺血性心肌病變

第10章 心臟移植市場（依移植保存）

  • 機械灌注
    • 低溫灌注
    • 常溫灌注
  • 靜態冷藏保管

第 11 章心臟移植市場（依病患年齡層）

  • 成人
  • 老年人
  • 孩子們

第 12 章 心臟移植市場（依最終用戶）

  • 醫院
  • 移植中心

第13章心臟移植市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 心臟移植市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 心臟移植市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Astellas Pharma Inc.
    • Novartis AG
    • Bristol-Myers Squibb Company
    • Sanofi SA
    • Medtronic plc
    • Abbott Laboratories
    • Baxter International Inc.
    • TransMedics, Inc.
    • Paragonix Technologies, Inc.
    • LivaNova PLC
Product Code: MRR-437E9896A565

The Heart Transplant Market is projected to grow by USD 28.45 billion at a CAGR of 10.17% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 13.10 billion
Estimated Year [2025] USD 14.41 billion
Forecast Year [2032] USD 28.45 billion
CAGR (%) 10.17%

A focused orientation to contemporary clinical, supply chain, and strategic priorities that are reshaping heart transplant programs and stakeholder decision-making

This executive summary offers a focused orientation to the contemporary heart transplant landscape, synthesizing clinical advances, supply chain dynamics, regulatory influences, and operational priorities that shape program-level and industry-level strategy. The overview highlights critical inflection points that are redefining perioperative practice, organ preservation, donor-recipient matching, and cross-border logistics while clarifying the implications for hospital administrators, transplant centers, medical device developers, and health system purchasers.

Through integrated analysis of clinical protocols and industry developments, this summary frames the most consequential trends and tensions facing the ecosystem. It seeks to align clinical quality imperatives with procurement realities and technological opportunities. By emphasizing both immediate operational levers and medium-term strategic shifts, the content provides a pragmatic roadmap for stakeholders aiming to optimize outcomes, control costs, and accelerate adoption of high-value innovations. The intent is to enable informed conversations among clinicians, administrators, and supply chain leaders about priorities and investment decisions that will materially influence program resilience and patient outcomes moving forward.

How technological innovation in organ perfusion, surgical refinement, and care model redesign are catalyzing structural change across heart transplant delivery systems

The heart transplant field is undergoing transformative shifts driven by technological innovation, evolving clinical protocols, and changes in how organs are preserved and allocated. Advances in organ perfusion technologies are extending viable preservation times and broadening donor criteria, which in turn is altering surgical timing, recipient selection frameworks, and logistics models. Concurrently, refinement of surgical techniques and perioperative management is improving graft function and early survival, creating opportunities for centers to reconsider patient pathways and capacity planning.

Other forces of change include the integration of data-driven donor-recipient matching, improvements in immunosuppression strategies, and growing emphasis on multidisciplinary post-transplant care models that balance survival with long-term quality of life. The confluence of these developments is prompting hospitals and transplant centers to reassess infrastructure investments, staff competencies, and partnerships with device and preservation technology suppliers. As these shifts unfold, program leaders are increasingly required to adopt flexible procurement strategies and to collaborate across clinical, operational, and supply chain domains to capture clinical benefits while managing complexity and cost.

Assessing how 2025 tariff adjustments in the United States are altering procurement economics, supply chain resilience, and technology adoption decisions in heart transplant care

Policy changes enacted in 2025 by the United States, specifically tariff adjustments, have introduced a layer of complexity to the heart transplant supply chain that affects devices, preservation systems, and cross-border logistics. Tariffs on certain medical devices and components can increase landed costs for specialized equipment used in transplants, impacting procurement budgets at hospitals and transplant centers. When procurement costs rise, program directors face difficult trade-offs between retaining established suppliers and investing in emergent technologies that promise clinical advantages but may have higher initial acquisition costs.

Tariff-driven cost pressures also influence global distribution patterns for preservation media, single-use components, and perfusion platforms. Logistic adaptations have emerged as providers seek alternative sourcing strategies, localized inventories, and contractual protections to mitigate supply disruption risks. Additionally, tariffs may have indirect clinical implications by constraining the availability of particular consumables or limiting rapid deployment of new devices that require internationally manufactured components. To navigate this environment, stakeholders are engaging more proactively with suppliers on pricing, investing in redundancy for critical supplies, and reassessing total cost of ownership rather than upfront price alone, thereby preserving program resilience and clinical continuity.

Segment-focused clinical and operational realities across procedure, indication, preservation, age group, and end user that determine procurement and program implementation choices

Segment-level dynamics reveal distinct clinical and operational imperatives that must be integrated into program planning and vendor selection. Procedure distinctions between heterotopic and orthotopic transplant remain foundational to surgical decision-making, with orthotopic approaches subdivided into biatrial and bicaval techniques that influence perioperative management, complication profiles, and resource utilization. Such procedural categorical differences guide staffing models, training needs, and device compatibility assessments.

Indication-based segmentation highlights varied patient cohorts such as congenital heart disease, dilated cardiomyopathy, end-stage heart failure, and ischemic cardiomyopathy, each of which carries unique pre-transplant optimization requirements and post-transplant care pathways. These clinical indications also shape allocation priorities and anticipated comorbidity burdens, informing length-of-stay projections and long-term follow-up strategies. Graft preservation choices between machine perfusion and static cold storage, and within machine perfusion between hypothermic and normothermic modalities, affect transport logistics, perfusion staffing, and decisions around investment in perfusion platforms. Patient age group distinctions across adult, geriatric, and pediatric populations have meaningful implications for graft selection criteria, immunosuppression protocols, and rehabilitation planning. Lastly, end users such as hospitals and transplant centers vary in scale, case mix, and integration with broader health systems, which drives differences in purchasing structures, preferred contracting approaches, and readiness to adopt new preservation and monitoring technologies. Understanding how these segments interact is essential for aligning clinical protocols with procurement strategy and for tailoring implementation plans that deliver consistent outcomes across program types.

Regional differentiation in clinical adoption, regulatory complexity, and supply chain strategy across the Americas, Europe Middle East & Africa, and Asia-Pacific that shapes implementation pathways

Regional dynamics shape clinical practice patterns, regulatory environments, and supply chain architectures, creating distinct strategic priorities for stakeholders operating in different geographies. In the Americas, centers benefit from mature transplant networks and integrated data systems that support advanced donor-recipient matching and rapid adoption of preservation innovations, yet they must also contend with differential reimbursement landscapes and state-level regulatory variability that influence capital planning and procurement cycles.

In Europe, the Middle East & Africa, heterogeneity in regulatory frameworks and infrastructure maturity drives a two-speed market where leading transplant centers adopt cutting-edge technologies while many institutions focus on foundational capacity building and supply chain stabilization. This regional mix affects partnership models and distribution strategies. In the Asia-Pacific region, expanding clinical capacity, evolving regulatory pathways, and active investment in medical technology infrastructure are accelerating uptake of novel preservation and monitoring solutions, but logistical complexity across vast geographies and variances in reimbursement can influence market entry strategies and localization efforts. Across all regions, cross-border collaboration, harmonization of clinical protocols, and strategic alliances with local distributors remain decisive factors in successful technology deployment and program scaling.

Competitive dynamics characterized by technology innovators, established device manufacturers, and service alliances that prioritize clinical validation, integration, and flexible commercial models

The corporate landscape supporting heart transplant care is marked by a mix of specialized technology innovators, established medical device manufacturers, and service providers that support logistics and preservation. Innovators focused on machine perfusion and organ preservation systems are driving a shift away from traditional cold storage models through platform development, data-enabled monitoring, and integration with transport logistics. At the same time, larger device manufacturers are leveraging distribution scale, regulatory experience, and clinical relationships to accelerate market penetration and facilitate training programs for new technologies.

Strategic partnerships between technology developers, transplant centers, and logistics providers are becoming more common, combining clinical validation pathways with operational solutions to manage organ transport and device uptime. Companies that emphasize robust clinical evidence, user-centered design, and lifecycle service support tend to achieve greater acceptance among program directors. Additionally, firms that offer flexible commercial models-such as outcome-oriented contracts, managed service arrangements, or bundled procurement options-are gaining traction as customers seek to align clinical benefits with predictable budgetary outcomes. Competitive differentiation increasingly depends on demonstrating clinical value, enabling seamless integration into clinical workflows, and supporting post-deployment training and data analytics.

Actionable strategic measures for hospital executives, transplant center leaders, and vendors to align procurement, clinical practice, and partnerships for sustained program resilience and outcomes

Industry leaders and program directors should take decisive steps to align clinical goals with procurement and operational strategies. Prioritize investments in preservation platforms that have demonstrated improvements in organ viability and operational flexibility, and pair those acquisitions with robust training programs and cross-disciplinary protocols to ensure consistent use and benefit realization. Simultaneously, adopt procurement frameworks that evaluate total cost of ownership, supply redundancy, and service-level agreements to protect programs against supply interruptions and tariff-driven cost volatility.

Cultivate strategic partnerships with logistics and technology providers to co-design transport and preservation workflows that reduce ischemic time and improve predictability. Invest in data capture and analytics to measure clinical outcomes, identify process bottlenecks, and support evidence-based contracting. Finally, engage with policymakers and payers to communicate the clinical and economic value of advanced preservation technologies, seeking reimbursement models or innovative contracting approaches that align incentives for early adoption and long-term patient benefit. These coordinated actions will position programs to capture clinical gains while maintaining fiscal discipline and operational resilience.

A rigorous evidence synthesis combining clinical literature, stakeholder interviews, protocol analysis, and operational validation to produce actionable program-level insights

The research underpinning this executive summary synthesizes peer-reviewed clinical literature, regulatory guidance, operative technique analyses, and primary qualitative inputs from transplant clinicians, supply chain leaders, and technology developers. Data collection included structured interviews with multidisciplinary stakeholders, examination of clinical protocols and device instructions for use, and review of policy documents pertinent to procurement and tariff impacts. Analytical methods combined thematic qualitative synthesis with comparative assessment of operational requirements across procedural and preservation modalities.

To ensure relevance for practitioners and decision-makers, the methodology prioritized triangulation across clinical evidence, supplier capabilities, and real-world operational experience. Insights were validated through iterative consultations with transplant surgeons, perfusionists, and program administrators to align findings with frontline practice. The research explicitly focused on system-level implications and technological adoption considerations rather than on granular financial estimates, enabling practical recommendations suited to diverse institutional contexts and readiness levels.

Synthesis of clinical, operational, and strategic imperatives that will determine which transplant programs capture the benefits of innovation while preserving resilience and patient outcomes

In conclusion, the heart transplant domain is at an inflection point where clinical innovation, shifting preservation paradigms, and evolving supply chain dynamics are converging to redefine program strategy. Advances in perfusion technologies and refinements in surgical and perioperative care are creating opportunities to expand donor pools and improve outcomes, while policy changes and procurement challenges necessitate more sophisticated supply chain and contracting approaches. Successful programs will be those that integrate clinical and operational planning, adopt evidence-backed technologies with appropriate training and support, and structure procurement to manage cost volatility and supply risk.

Looking ahead, the most resilient transplant programs will be those that combine clinical excellence with strategic procurement, data-driven performance management, and collaborative partnerships across the clinical and commercial ecosystem. By aligning investments with validated clinical benefits and operational readiness, stakeholders can improve patient outcomes, enhance program sustainability, and accelerate the adoption of innovations that meaningfully advance transplant care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing use of machine learning algorithms to predict donor heart suitability and post-transplant survival outcomes
  • 5.2. Adoption of ex vivo heart perfusion systems for extending donor heart preservation time and improving graft function
  • 5.3. Regulatory approval and clinical integration of xenotransplantation using gene-edited pig hearts to address donor shortages
  • 5.4. Advances in immunomodulatory therapies targeting B-cell depletion to reduce chronic rejection rates in heart transplant recipients
  • 5.5. Integration of wearable telemonitoring devices for early detection of graft rejection and personalized patient management
  • 5.6. Impact of 3D bioprinting research on development of autologous cardiac tissue scaffolds to mitigate organ scarcity
  • 5.7. Emergence of donor-specific cell therapy to enhance tolerance and minimize lifelong immunosuppression regimens post-transplant
  • 5.8. Expansion of donation after circulatory death protocols to increase donor availability and reduce waiting list mortality
  • 5.9. Implementation of AI-driven decision support tools to optimize organ allocation and improve transplant center workflows

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Heart Transplant Market, by Procedure

  • 8.1. Heterotopic Transplant
  • 8.2. Orthotopic Transplant
    • 8.2.1. Biatrial Technique
    • 8.2.2. Bicaval Technique

9. Heart Transplant Market, by Indication

  • 9.1. Congenital Heart Disease
  • 9.2. Dilated Cardiomyopathy
  • 9.3. End Stage Heart Failure
  • 9.4. Ischemic Cardiomyopathy

10. Heart Transplant Market, by Graft Preservation

  • 10.1. Machine Perfusion
    • 10.1.1. Hypothermic Perfusion
    • 10.1.2. Normothermic Perfusion
  • 10.2. Static Cold Storage

11. Heart Transplant Market, by Patient Age Group

  • 11.1. Adult
  • 11.2. Geriatric
  • 11.3. Pediatric

12. Heart Transplant Market, by End User

  • 12.1. Hospitals
  • 12.2. Transplant Centers

13. Heart Transplant Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Heart Transplant Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Heart Transplant Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Astellas Pharma Inc.
    • 16.3.2. Novartis AG
    • 16.3.3. Bristol-Myers Squibb Company
    • 16.3.4. Sanofi S.A.
    • 16.3.5. Medtronic plc
    • 16.3.6. Abbott Laboratories
    • 16.3.7. Baxter International Inc.
    • 16.3.8. TransMedics, Inc.
    • 16.3.9. Paragonix Technologies, Inc.
    • 16.3.10. LivaNova PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS HEART TRANSPLANT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. HEART TRANSPLANT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. HEART TRANSPLANT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HEART TRANSPLANT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HEART TRANSPLANT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HEART TRANSPLANT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HETEROTOPIC TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HETEROTOPIC TRANSPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HETEROTOPIC TRANSPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HETEROTOPIC TRANSPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HETEROTOPIC TRANSPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HETEROTOPIC TRANSPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BIATRIAL TECHNIQUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BIATRIAL TECHNIQUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BIATRIAL TECHNIQUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BIATRIAL TECHNIQUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BIATRIAL TECHNIQUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BIATRIAL TECHNIQUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BICAVAL TECHNIQUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BICAVAL TECHNIQUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BICAVAL TECHNIQUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BICAVAL TECHNIQUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BICAVAL TECHNIQUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BICAVAL TECHNIQUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEART TRANSPLANT MARKET SIZE, BY CONGENITAL HEART DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HEART TRANSPLANT MARKET SIZE, BY CONGENITAL HEART DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEART TRANSPLANT MARKET SIZE, BY CONGENITAL HEART DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HEART TRANSPLANT MARKET SIZE, BY CONGENITAL HEART DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEART TRANSPLANT MARKET SIZE, BY CONGENITAL HEART DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HEART TRANSPLANT MARKET SIZE, BY CONGENITAL HEART DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEART TRANSPLANT MARKET SIZE, BY DILATED CARDIOMYOPATHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HEART TRANSPLANT MARKET SIZE, BY DILATED CARDIOMYOPATHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEART TRANSPLANT MARKET SIZE, BY DILATED CARDIOMYOPATHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HEART TRANSPLANT MARKET SIZE, BY DILATED CARDIOMYOPATHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEART TRANSPLANT MARKET SIZE, BY DILATED CARDIOMYOPATHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HEART TRANSPLANT MARKET SIZE, BY DILATED CARDIOMYOPATHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END STAGE HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END STAGE HEART FAILURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END STAGE HEART FAILURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END STAGE HEART FAILURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END STAGE HEART FAILURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END STAGE HEART FAILURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ISCHEMIC CARDIOMYOPATHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ISCHEMIC CARDIOMYOPATHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ISCHEMIC CARDIOMYOPATHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ISCHEMIC CARDIOMYOPATHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ISCHEMIC CARDIOMYOPATHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ISCHEMIC CARDIOMYOPATHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HYPOTHERMIC PERFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HYPOTHERMIC PERFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HYPOTHERMIC PERFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HYPOTHERMIC PERFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HYPOTHERMIC PERFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HYPOTHERMIC PERFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEART TRANSPLANT MARKET SIZE, BY NORMOTHERMIC PERFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HEART TRANSPLANT MARKET SIZE, BY NORMOTHERMIC PERFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEART TRANSPLANT MARKET SIZE, BY NORMOTHERMIC PERFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HEART TRANSPLANT MARKET SIZE, BY NORMOTHERMIC PERFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEART TRANSPLANT MARKET SIZE, BY NORMOTHERMIC PERFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HEART TRANSPLANT MARKET SIZE, BY NORMOTHERMIC PERFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEART TRANSPLANT MARKET SIZE, BY STATIC COLD STORAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HEART TRANSPLANT MARKET SIZE, BY STATIC COLD STORAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEART TRANSPLANT MARKET SIZE, BY STATIC COLD STORAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HEART TRANSPLANT MARKET SIZE, BY STATIC COLD STORAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEART TRANSPLANT MARKET SIZE, BY STATIC COLD STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HEART TRANSPLANT MARKET SIZE, BY STATIC COLD STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GERIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS HEART TRANSPLANT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS HEART TRANSPLANT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
  • TABLE 263. ASEAN HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
  • TABLE 264. ASEAN HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. GCC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GCC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GCC HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 272. GCC HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 273. GCC HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
  • TABLE 274. GCC HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
  • TABLE 275. GCC HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 276. GCC HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 277. GCC HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
  • TABLE 278. GCC HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
  • TABLE 279. GCC HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
  • TABLE 280. GCC HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
  • TABLE 281. GCC HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GCC HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GCC HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. GCC HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. BRICS HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 304. BRICS HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 305. BRICS HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
  • TABLE 306. BRICS HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
  • TABLE 307. BRICS HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 308. BRICS HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 309. BRICS HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
  • TABLE 310. BRICS HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
  • TABLE 311. BRICS HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
  • TABLE 312. BRICS HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
  • TABLE 313. BRICS HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 314. BRICS HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 315. BRICS HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. BRICS HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. G7 HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. G7 HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. G7 HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 320. G7 HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 321. G7 HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
  • TABLE 322. G7 HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
  • TABLE 323. G7 HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 324. G7 HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 325. G7 HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
  • TABLE 326. G7 HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
  • TABLE 327. G7 HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
  • TABLE 328. G7 HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
  • TABLE 329. G7 HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 330. G7 HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 331. G7 HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. G7 HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. NATO HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 334. NATO HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 335. NATO HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 336. NATO HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 337. NATO HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
  • TABLE 338. NATO HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
  • TABLE 339. NATO HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 340. NATO HEART TRANSPLANT MARKET SIZE, BY IND